CRISPR Therapeutics AG (CRSP)

53.39 +2.95 (+5.85%) USD  |  NASDAQ  |  Oct 09, 16:00
53.37 -0.02 (-0.04%) After-Hours: 20:00
More

CRISPR Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Basilea Pharmaceutica AG Upgrade
Santhera Pharmaceuticals Holding AG Upgrade
BeOne Medicines Ltd. Upgrade
AC Immune SA Upgrade